AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS: AXIM · Delayed Price · USD
0.0087
-0.0003 (-3.33%)
Jun 17, 2024, 10:21 AM EDT - Market open

AXIM Biotechnologies Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 2011
Revenue
0.040.010.0600.8
Upgrade
Revenue Growth (YoY)
345.27%-85.32%--308.70%
Upgrade
Cost of Revenue
0.430.4300.020.58
Upgrade
Gross Profit
-0.39-0.420.06-0.020.22
Upgrade
Selling, General & Admin
2.244.085.674.514.27
Upgrade
Research & Development
0.130.150.280.432.45
Upgrade
Other Operating Expenses
-0.080.431.84-0.10
Upgrade
Operating Expenses
2.364.667.794.836.73
Upgrade
Operating Income
-2.75-4.65-7.99-4.95-6.51
Upgrade
Interest Income
00000.3
Upgrade
Interest Expense
1.21.880.490.320.32
Upgrade
Other Expense / Income
4.1-0.297.551.02-0.08
Upgrade
Pretax Income
-8.06-6.24-16.02-6.29-6.45
Upgrade
Income Tax
0-0.290.490.440.32
Upgrade
Net Income
-8.06-5.96-16.52-6.73-6.77
Upgrade
Shares Outstanding (Basic)
22816513211062
Upgrade
Shares Outstanding (Diluted)
22816513211062
Upgrade
Shares Change
37.60%25.79%19.16%78.19%8.14%
Upgrade
EPS (Basic)
-0.04-0.04-0.13-0.06-0.11
Upgrade
EPS (Diluted)
-0.04-0.04-0.13-0.06-0.11
Upgrade
Free Cash Flow
-1.03-2.05-2.54-3.31-5.02
Upgrade
Free Cash Flow Per Share
-0.00-0.01-0.02-0.03-0.08
Upgrade
Gross Margin
-980.57%-4701.42%100.00%-27.99%
Upgrade
Operating Margin
-6960.98%-52425.60%-13207.09%--813.73%
Upgrade
Profit Margin
-20394.96%-67120.74%-27320.76%--846.98%
Upgrade
Free Cash Flow Margin
-2607.67%-23132.80%-4196.59%--627.92%
Upgrade
EBITDA
-2.32-4.23-5.87-4.82-6.5
Upgrade
EBITDA Margin
-5880.41%-47621.28%-9707.77%--812.92%
Upgrade
Depreciation & Amortization
0.430.432.120.020.01
Upgrade
EBIT
-2.75-4.65-7.99-4.83-6.51
Upgrade
EBIT Margin
-6960.98%-52422.70%-13207.09%--813.73%
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.